Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥20.2bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥36.2bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥18.1bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥2.5bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥1.5bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥2.4bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥1.7bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.3bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥2.4bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥2.3bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥1.9bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.2bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.1bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.9bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥2.1bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥84.4bnat 2024-09-30Cons.Assets
Total assets¥81.8bnat 2024-03-31Cons.Assets
Total assets¥79.6bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥9.1bnat 2024-09-30Cons.Liabilities
Total liabilities¥9.5bnat 2024-03-31Cons.Liabilities
Net assets / equity¥75.3bnat 2024-09-30Cons.Net assets
Net assets / equity¥72.3bnat 2024-03-31Cons.Net assets
Net assets / equity¥71.5bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥16.9bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥15.4bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥19.8bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥18.7bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥21.0bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥25.8bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥3.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥513m2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥490m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥7.2bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥732m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.5bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥731m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥35.392024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥40.082023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥38.542023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio89.2%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio88.4%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.9%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E00970-000LALreportable segmentrevenue2024-04-01 → 2024-09-30¥5.9bn
jpcrp040300-q2r_E00970-000LALreportable segmentrevenue external2024-04-01 → 2024-09-30¥5.9bn
jpcrp040300-q2r_E00970-000LALreportable segmentsegment profit2024-04-01 → 2024-09-30¥481m
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentrevenue2024-04-01 → 2024-09-30¥14.3bn
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentrevenue external2024-04-01 → 2024-09-30¥14.3bn
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentsegment profit2024-04-01 → 2024-09-30¥2.1bn
—segment totalrevenue2024-04-01 → 2024-09-30¥20.2bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥20.2bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥2.5bn
jpcrp040300-q2r_E00970-000LALreportable segmentrevenue2023-04-01 → 2023-09-30¥5.0bn
jpcrp040300-q2r_E00970-000LALreportable segmentrevenue external2023-04-01 → 2023-09-30¥5.0bn
jpcrp040300-q2r_E00970-000LALreportable segmentsegment profit2023-04-01 → 2023-09-30¥420m
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentrevenue2023-04-01 → 2023-09-30¥13.1bn
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentrevenue external2023-04-01 → 2023-09-30¥13.1bn
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentsegment profit2023-04-01 → 2023-09-30¥1.1bn
—segment totalrevenue2023-04-01 → 2023-09-30¥18.1bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥18.1bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥1.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 518
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember7293000
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.1336
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember6454000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.1183
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember1645000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0301
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember1573000
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0288
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember1536000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0282
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember1207000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0221
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember828000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0152
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember752000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0138
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember688000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0126
Number of shares heldCurrentQuarterInstant29821000
Shareholding ratioCurrentQuarterInstant0.5464
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember2236300
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember54527100
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember545271
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember50693
Number of shares issued shares voting rightsCurrentQuarterInstant56814093
Number of voting rights issued shares voting rightsCurrentQuarterInstant545271
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member2236300
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member2236300
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0394
Number of shares held in own name treasury shares etcCurrentQuarterInstant2236300
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant2236300
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0394
Cash and depositsPrior1YearInstant15439000000JPY
Cash and depositsCurrentQuarterInstant16882000000JPY
Notes receivable tradePrior1YearInstant69000000JPY
Notes receivable tradeCurrentQuarterInstant51000000JPY
Accounts receivable tradePrior1YearInstant8172000000JPY
Accounts receivable tradeCurrentQuarterInstant7356000000JPY
Short term investment securitiesPrior1YearInstant5592000000JPY
Short term investment securitiesCurrentQuarterInstant3381000000JPY
Merchandise and finished goodsPrior1YearInstant3201000000JPY
Merchandise and finished goodsCurrentQuarterInstant3902000000JPY
Work in processPrior1YearInstant3120000000JPY
Work in processCurrentQuarterInstant3602000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass